NASDAQ
Better Therapeutics, Inc. (BTTX) has a free cash flow growth of -6.40% as of Friday, May 29, 2026. This represents a 449.17% decrease compared to its 12-month average of 1.83%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.